NOVARTIS AG BASEL AKT (NVSEF) Debt by Year
NOVARTIS AG BASEL AKT carried $28.7B in long-term debt against $11.4B in cash and equivalents at the end of fiscal year 2025. Long-term debt rose 16.2% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters NOVARTIS AG BASEL AKT has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
NVSEF Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $28.7B+16.2% | $24.7B+19.9% | $20.6B-8.3% | $22.5B-11.9% | $25.5B-10.5% | $28.5B+27.6% | $22.4B-12.9% | $25.7B+8.8% | $23.6B+30.5% | $18.1B | N/A |
| Cash & Equivalents | $11.4B-0.2% | $11.5B-14.4% | $13.4B+78.2% | $7.5B-39.4% | $12.4B+28.5% | $9.7B-13.1% | $11.1B-16.3% | $13.3B+49.8% | $8.9B+26.4% | $7.0B+49.9% | $4.7B |
NVSEF Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q2'256-K | Q4'2420-F | Q2'246-K | Q4'2320-F | Q2'236-K | Q4'2220-F | Q2'226-K | Q4'2120-F | Q2'216-K | Q4'2020-F | Q2'206-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $28.7B+16.2% | N/A | $24.7B+19.9% | N/A | $20.6B-8.3% | N/A | $22.5B-11.9% | N/A | $25.5B-10.5% | N/A | $28.5B+27.6% | N/A |
| Cash & Equivalents | $11.4B-0.2% | $6.7B-15.8% | $11.5B-14.4% | $7.9B-27.4% | $13.4B+78.2% | $10.9B+200.3% | $7.5B-39.4% | $3.6B-29.2% | $12.4B+28.5% | $5.1B-13.5% | $9.7B-13.1% | $5.9B-40.8% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More NOVARTIS AG BASEL AKT financials
Frequently Asked Questions
What was NOVARTIS AG BASEL AKT's long-term debt in fiscal year 2025?
NOVARTIS AG BASEL AKT carried $28.7B in long-term debt against $11.4B in cash and equivalents at the end of fiscal year 2025.
How fast is NOVARTIS AG BASEL AKT's long-term debt growing?
NOVARTIS AG BASEL AKT (NVSEF) long-term debt rose by 16.2% year over year, from $24.7B to $28.7B in fiscal year 2025.
What was NOVARTIS AG BASEL AKT's long-term debt in the most recent quarter?
NOVARTIS AG BASEL AKT (NVSEF) reported $28.7B in long-term debt in Q4 2025. This represents an increase of 16.2% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what NOVARTIS AG BASEL AKT (NVSEF) reported on that line in every period on record.